Canaccord Genuity Group Reaffirms “Hold” Rating for Beauty Health (NASDAQ:SKIN)

Beauty Health (NASDAQ:SKIN)‘s stock had its “hold” rating reaffirmed by stock analysts at Canaccord Genuity Group in a research note issued on Friday,Benzinga reports. They presently have a $1.50 price target on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 19.52% from the company’s previous close.

Several other research analysts have also recently commented on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a report on Wednesday, January 14th. Zacks Research downgraded shares of Beauty Health from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 21st. TD Cowen raised their price objective on shares of Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a research note on Wednesday, January 21st. Finally, Benchmark reiterated a “hold” rating on shares of Beauty Health in a research report on Friday. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $2.45.

Beauty Health Trading Up 18.4%

Shares of Beauty Health stock traded up $0.20 on Friday, reaching $1.26. 1,630,275 shares of the company were exchanged, compared to its average volume of 633,203. Beauty Health has a fifty-two week low of $0.78 and a fifty-two week high of $2.69. The firm has a market capitalization of $160.01 million, a price-to-earnings ratio of -5.70 and a beta of 1.20. The company has a current ratio of 4.98, a quick ratio of 4.07 and a debt-to-equity ratio of 5.53. The stock has a fifty day moving average price of $1.27 and a 200-day moving average price of $1.52.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The business had revenue of $82.37 million during the quarter, compared to analyst estimates of $78.07 million. Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%. On average, analysts expect that Beauty Health will post -0.25 EPS for the current year.

Hedge Funds Weigh In On Beauty Health

A number of large investors have recently made changes to their positions in SKIN. AQR Capital Management LLC acquired a new stake in shares of Beauty Health during the first quarter worth approximately $40,000. Goldman Sachs Group Inc. lifted its position in Beauty Health by 5.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock worth $892,000 after buying an additional 31,880 shares in the last quarter. ProShare Advisors LLC lifted its position in Beauty Health by 45.5% in the 2nd quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock worth $45,000 after buying an additional 7,336 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Beauty Health by 27.5% during the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after buying an additional 496,963 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey grew its holdings in shares of Beauty Health by 87.5% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company’s stock valued at $60,000 after acquiring an additional 14,653 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Trending Headlines about Beauty Health

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Q4 revenue and EPS came in ahead of some street estimates — revenue $82.4M (beat consensus) and EPS of ($0.06) that compared favorably to the company’s prior-year loss; management highlighted improving utilization of its installed Hydrafacial base and innovation initiatives as drivers for growth. Press Release
• Positive Sentiment: Management set FY2026 revenue guidance of $285M–$305M while emphasizing installed-base utilization and new product innovation — a clear signal the company expects revenue growth driven by equipment attach, consumables and services. Article: Revenue Target
• Neutral Sentiment: Management hosted an earnings call and released the transcript/slide deck; details on cadence of new product rollouts and install-base monetization will be important to monitor for execution risk and timing. Earnings Transcript
• Negative Sentiment: Q1 2026 revenue guidance of $63M–$68M was slightly below consensus (~$68.6M), and FY revenue midpoint (~$295M) is modestly under some analyst expectations — a conservative near-term guide that can temper upside. Earnings Call Transcript
• Negative Sentiment: Profitability remains weak: the company reported a small operating profit but a net loss and lower cash year-over-year; leverage metrics remain elevated — these fundamentals keep the risk profile higher for equity holders. QuiverQuant Summary

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.